Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity.

Autor: Di Mascolo D; Department of Translational Imaging and Department of Nanomedicine, The Methodist Hospital Research Institute, 6670 Bertner Ave, Houston 77030, USA., J Lyon C, Aryal S, Ramirez MR, Wang J, Candeloro P, Guindani M, Hsueh WA, Decuzzi P

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2013 Sep 28; Vol. 170 (3), pp. 460-8. Date of Electronic Publication: 2013 Jun 18.